Loading...

SUN-179 Prolonged Hypoglycemia from Insulin Degludec

Prolonged Hypoglycemia from Insulin Degludec Background:  Patients with type 2 diabetes treated with insulin degludec compared with insulin glargine had a reduced risk of overall symptomatic hypoglycemia (1). This is primarily due to former’s long half-life (25 hours) and lack of trough lev...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Endocr Soc
Main Authors: Kothari, Vallari, Reutrakul, Sirimon
Format: Artigo
Sprog:Inglês
Udgivet: Endocrine Society 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553236/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-179
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!